Evidence map›Paper›PMID 35855067›Full record

ArticleGlobal health & medicine2022

Investigation of the use of PCR testing prior to ship boarding to prevent the spread of SARS-CoV-2 from urban areas to less-populated remote islands.

Junko Terada-Hirashima, Wataru Sugiura, Yosuke Shimizu, Yurika Tanaka, Yukari Uemura, Masahiro Ishikane, Yukumasa Kazuyama, Masato Ikeda, Kazuhiko Wakabayashi, Norio Ohmagari and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Global health & medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Junko Terada-HirashimaDepartment of Clinical Research Promotion, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Wataru SugiuraCenter for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Yosuke ShimizuDepartment of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Yurika TanakaDepartment of Academic-Industrial Partnerships Promotion, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Yukari UemuraDepartment of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Masahiro IshikaneDisease Control and Prevention Center, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.
Yukumasa KazuyamaSB Coronavirus Inspection Center Corp., Tokyo, Japan.
Masato IkedaSB Coronavirus Inspection Center Corp., Tokyo, Japan.
Kazuhiko WakabayashiTokyo Metropolitan Government Bureau of General Affairs, Tokyo, Japan.
Norio OhmagariDisease Control and Prevention Center, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.
Moto KimuraDepartment of Academic-Industrial Partnerships Promotion, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
National Center for Global Health and Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preventing coronavirus disease (COVID-19) outbreaks and the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from urban areas to less-populated remote islands, many of which may have weak medical systems, is an important issue. Here, we evaluated the usefulness of pre-boarding, saliva-based polymerase chain reaction (PCR) screening tests to prevent the spread of SARS-CoV-2 from Tokyo to the remote island of Chichijima. The infection rate on the island during the study period from September 1, 2020 to March 21, 2021 was 0.015% (2/13,446). Of the 8,910 individuals tested before ship boarding, seven tested positive for COVID-19 (PCR tests of saliva samples). One was confirmed positive by subsequent confirmatory nasopharyngeal swab testing. Based on the testing results, positive cases were denied entry onto the ship to prevent the spread of COVID-19 from Tokyo to Chichijima. This study demonstrated that implementing pre-boarding PCR screening tests is a useful strategy that can be applied to other remote islands with vulnerable medical systems.

Indexed as

COVID-19pre-boarding screensaliva-based polymerase chain reaction

Identifiers

PMID35855067
PMCPMC9243411
OpenAlexW4285192744

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.